1,25-Dihydroxyvitamin D3 up-regulates expression of hsa-let-7a-2 through the interaction of VDR/VDRE in human lung cancer A549 cells

Gene

Volumn 522, Issue 2, 2013, Pages 142-146

  Guan, Hengyun ^a,b   Liu, Chunyan ^a   Chen, Zhaobo ^a   Wang, Lina ^a   Li, Chaoyang ^a   Zhao, Jian ^c   Yu, Yang ^a   Zhang, Pengju ^a   Chen, Weiwen ^a   Jiang, Anli ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Jinan Center for Disease Control and Prevention   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

1,25(OH)2VD3; Hsa let 7a 2; Lung cancer cell; VDRE

Indexed keywords

CALCITRIOL; HSA LET 7A PROTEIN; LUCIFERASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; UPREGULATION; VITAMIN D RESPONSIVE ELEMENT;

CALCITRIOL; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; LUNG NEOPLASMS; MICRORNAS; PROTEIN BINDING; RECEPTORS, CALCITRIOL; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; VITAMIN D RESPONSE ELEMENT;

EID: 84878110531     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.03.065     Document Type: Article

References (46)

1. Ali M.M., Vaidya V. Vitamin D and cancer. J. Cancer Res. Ther. 2007, 3:225-230.
2. Campbell M.J., Koeffler H.P. Toward therapeutic intervention of cancer by vitamin D compounds. J. Natl. Cancer Inst. 1997, 89:182-185.
3. Cheung F.S., Lovicu F.J., Reichardt J.K. Current progress in using vitamin D and its analogs for cancer prevention and treatment. Expert. Rev. Anticancer. Ther. 2012, 12(6):811-837.
4. Deeb K.K., Trump D.L., Johnson C.S. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer 2007, 7(9):684-700.
5. Dogan I., et al. Polymorphisms in the vitamin D receptor gene and risk of lung cancer. Med. Sci. Monit. 2009, 15:232-242.
6. Eder M., Scherr M. MicroRNA and lung cancer. N. Engl. J. Med. 2005, 352:2446-2448.
7. Flores O., Burnstein K.L. GADD45gamma: a new vitamin D-regulated gene that is antiproliferative in prostate cancer cells. Endocrinology 2010, 151:4654-4664.
8. Gocek E., Studzinski G.P. Vitamin D and differentiation in cancer. Crit. Rev. Clin. Lab. Sci. 2009, 46:190-209.
9. Haussler M.R., et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res. 1998, 13:325-349.
10. He X., et al. Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. FEBS Lett. 2009, 583:3501-3507.
11. He X.Y., Chen J.X., Zhang Z., Li C.L., Peng Q.L., Peng H.M. The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice. J. Cancer Res. Clin. Oncol. 2010, 136:1023-1028.
12. Hershberger P.A., Modzelewski R.A., Shurin Z.R. 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res. 1999, 59:2644-2649.
13. Higashimoto Y., et al. 1a, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line. Anticancer. Res. 1996, 16:2653-2659.
14. Jiang L., et al. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem. J. 2010, 432:199-205.
15. Johnson S.M., et al. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647.
16. Johnson C.D., Esquela-Kerscher A., Stefani G. The let-7 MicroRNA represses cell proliferation pathways in human cells. Cancer Res. 2007, 67:7713-7722.
17. Jones G., Strugnell S.A., DeLuca H. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 1998, 78:1193-1231.
18. Kanli A., Savli H. Differential expression of 16 genes coding for cell cycle- and apoptosis-related proteins in vitamin D-induced differentiation of HL-60 cells. Exp. Oncol. 2007, 29:314-316.
19. Kefas B., et al. MicroRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 2008, 68:3566-3572.
20. Kilkkinen A., et al. Vitamin D status and the risk of lung cancer: a cohort study in Finland. Cancer Epidemiol. Biomarkers Prev. 2008, 17:3274-3278.
21. Kumar M.S., et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:3903-3908.
22. Liu W., et al. Characterization of two functional NKX3.1 binding sites upstream of the PCAN1 gene that are involved in the positive regulation of PCAN1 gene transcription. BMC Mol. Biol. 2008, 9:45. (May).
23. Mangelsdorf D.J., et al. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
24. Nakagawa K., Kawaura A., Kato S. Metastatic growth of lung cancer cells is extremely reduced in Vitamin D receptor knockout mice. J. Steroid Biochem. Mol. Biol. 2004, 89-90:545-547.
25. Nakagawa K., Kawaura A., Kato S., Takeda E., Okano T. 1alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer. Carcinogenesis 2005, 26:429-440.
26. Ortholan C., Puissegur M.P., Ilie M., Barbry P., Mari B., Hofman P. MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. Curr. Med. Chem. 2009, 16:1047-1061.
27. Pan L., et al. Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A/sodium butyrate- induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation. FEBS J. 2010, 277:989-999.
28. Pendás-Franco N., González-Sancho J.M., Suárez Y. Vitamin D regulates the phenotype of human breast cancer cells. Differentiation 2007, 75:193-207.
29. Ramnath N., Kim S., Christensen P.J. Vitamin D and lung cancer. Expert Rev. Respir. Med. 2011, 5:305-309.
30. Raponi M., et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res. 2009, 69:5776-5783.
31. Samuel S., Sitrin M.D. Vitamin D's role in cell proliferation and differentiation. Nutr. Rev. 2008, 66:116-124.
32. Saydam O., Senol O., Würdinger T., Mizrak A., Ozdener G.B., Stemmer-Rachamimov A.O. miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Res. 2011, 71:852-861.
33. Srinivasan M., Parwani A.V., Hershberger P.A., Lenzner D.E., Weissfeld J.L. Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer. J. Steroid Biochem. Mol. Biol. 2011, 123:30-36.
34. Takamizawa J., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004, 64:3753-3756.
35. Wang X., Patel R., Studzinski G.P. hKSR-2, a vitamin D-regulated gene, inhibits apoptosis in arabinocytosine-treated HL60 leukemia cells. Mol. Cancer Ther. 2008, 7:2798-2806.
36. Wang X., Gocek E., Novik V., Harrison J.S., Danilenko M., Studzinski G.P. Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and up-regulates p27Kip1 concomitant with enhancement ofdifferentiation and cell cycle arrest induced by silibinin and 1,25-dihydroxy- vitamin D3. Cell Cycle 2010, 9:4542-4551.
37. Wang W.L., Chatterjee N., Chittur S.V., Welsh J., Tenniswood M.P. Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol. Cancer 2011, 18:58-73.
38. Xiong S., Zheng Y., Jiang P., Liu R., Liu X., Chu Y. MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2. Int. J. Biol. Sci. 2011, 7:805-814.
39. Yanaihara N., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
40. Yang J., Ikezoe T., Nishioka C., Ni L., Koeffler H.P., Yokoyama A. Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1,25-dihydroxyvitamin D(3) to induce growth arrest anddifferentiation of AML cells in vitro and in vivo. Exp. Hematol. 2010, 38:666-676.
41. Young M.R., Ihm J., Lozano Y., Wright M.A., Prechel M.M. Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunol. Immunother. 1995, 41:37-45.
42. Yu S.L., et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13:48-57.
43. Zhou W., et al. Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2303-2309.
44. Zhou W., et al. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol. Biomarkers Prev. 2006, 15:2239-2245.
45. Zhou W., et al. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J. Clin. Oncol. 2007, 25:479-485.
46. Zhuang S.H., Bernstein K.L. Antiproliferative effect of 1a, 25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology 1998, 139:1197-1207.